Clomipramine could be useful in preventing neurological complications of SARS-CoV-2 infection
B Nobile, M Durand, E Olié, S Guillaume… - Journal of Neuroimmune …, 2020 - Springer
Dear Dr. Gendelman, The global pandemic of the new coronavirus disease 2019 (COVID-
19) has affected more than 7 million of people and provoked more than 400,000 deaths …
19) has affected more than 7 million of people and provoked more than 400,000 deaths …
The anti-inflammatory effect of the tricyclic antidepressant clomipramine and its high penetration in the brain might be useful to prevent the psychiatric consequences …
B Nobile, M Durand, E Olié, S Guillaume… - Frontiers in …, 2021 - frontiersin.org
At the time of writing (December 2020), coronavirus disease 2019 (COVID-19) has already
caused more than one million deaths worldwide, and therefore, it is imperative to find …
caused more than one million deaths worldwide, and therefore, it is imperative to find …
Feasibility of therapeutic effects of the cholinergic anti-inflammatory pathway on COVID-19 symptoms
R Mazloom - Journal of Neuroimmune Pharmacology, 2020 - Springer
Dear editor Coronavirus disease 2019 (COVID-19) spread around the world quickly, which
results in morbidity and mortality. COVID-19 harms various human functional systems …
results in morbidity and mortality. COVID-19 harms various human functional systems …
[HTML][HTML] Putative mechanisms explaining neuro-COVID
J Finsterer - Journal of Neuroimmunology, 2021 - ncbi.nlm.nih.gov
With interest we read the article by Kayhanian et al. about the presumed neuro-
immunological mechanisms underlying the involvement of the central nervous system (CNS) …
immunological mechanisms underlying the involvement of the central nervous system (CNS) …
Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients
COVID-19 is a pandemic caused by human coronavirus (HCoV) SARS-CoV-2, which
originated in Wuhan, China, at the end of 2019 and spread globally during 2020. Due to the …
originated in Wuhan, China, at the end of 2019 and spread globally during 2020. Due to the …
Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19?
P Grieb, K Rejdak - Folia Neuropathologica, 2021 - termedia.pl
The majority of COVID-19 cases are only mildly or moderately symptomatic, but in some
patients excessive inflammatory response becomes the dominant factor of disease …
patients excessive inflammatory response becomes the dominant factor of disease …
SARS-CoV-2 infection leads to neurological dysfunction
A number of neurological disease complications have been seen following infection with the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While most person with …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While most person with …
May the central nervous system be fogged by the cytokine storm in COVID-19?: an appraisal
Dysfunction”(Acharya et al. 2020). They have reviewed current literature on the neurological
complications and manifestations of COVID-19, however, they were able to identify only a …
complications and manifestations of COVID-19, however, they were able to identify only a …
Neuropsychiatric disorders and COVID-19: what we know so far
F Majolo, GL Silva, L Vieira, C Anli, LFSM Timmers… - Pharmaceuticals, 2021 - mdpi.com
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) affects the central
nervous system (CNS), which is shown in a significant number of patients with neurological …
nervous system (CNS), which is shown in a significant number of patients with neurological …
Coronavirus disease 2019 (COVID-19) and its neuroinvasive capacity: Is it time for melatonin?
The world faces an exceptional new public health concern caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), subsequently termed the coronavirus …
respiratory syndrome coronavirus 2 (SARS-CoV-2), subsequently termed the coronavirus …